Therapeutic effect of a new synthetic lipid a analog (ONO-4007) on a tumor implanted at different sites in rats

Journal of Immunotherapy

Volumn 22, Issue 5, 1999, Pages 401-406

  Mizushima, Yutaka ^a,b   Sassa, Kazuhiko ^a   Fujishita, Takashi ^a   Oosaki, Rokuo ^a   Kobayashi, Masashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Antitumor effect; Endotoxin; Lipid A analog; ONO 4007; Tumor necrosis factor

Indexed keywords

2 DEOXY 3 O (9 PHENYLNONANOYL) 2 [3 (9 PHENYLNONANOYLOXY)TETRADECANOYLAMINO]GLUCOPYRANOSE 4 SULFATE; CARBOPLATIN; CYCLOPHOSPHAMIDE; LIPID A DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CYCLOPHOSPHAMIDE; GROWTH INHIBITORS; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LIPID A; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032828891     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199909000-00003     Document Type: Article

References (21)

1. Luderitz O, Galanos C, Lehmann V, et al. Lipid A: chemical structure and biological activity. J Infect Dis 1973;128(suppl. I): 17-29.
2. Ogawa Y, Fujishima Y, Ishida H, Kiso M, Hasegawa A. Synthesis of a novel series of 4-O-phosphono-D-glucosamine derivatives (lipid A subunit analogs) carrying the c-branched 2 tetradecylhexa-dexananoyl group. Carbohydr Res 1991;220:155-64.
3. Nakatsukasa M, Kumazawa Y, Homma JY, Kiso M, Hasegawa A. Inhibition in mice of experimental metastasis of B16 melanoma by the synthetic lipid-A subunit analogue GLA-60. Int J Immunophar-macol 1991;13:11-19.
4. Sato K, Saiki I, Yoo YC, et al. DT-5461, a new synthetic lipid A analogue, inhibits lung and liver metastasis of tumor in mice. Jpn J Cancer Res 1992;83:1081-7.
5. Kobayashi M, Nagayasu H, Hamada J, Takeichi N, Hosokawa M. ONO-4007, a new synthetic lipid A derivative, induces differentiation of rat myelomonocytic leukemia cells in vitro and in vivo. Exp Hematol 1994;22:454-9.
6. Yang D, Satoh M, Ueda H, Tsukagoshi S, Yamazaki M. Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects. Cancer Immunol Immunother 1994;38:287-93.
7. Satake K, Yokomatsu H, Hiura A. Effects of a new synthetic lipid A on endogenous tumor necrosis factor production and antitumor activity against human panceatic cancer cells. Pancreas 1996;12:260-6.
8. Matsumoto N, Aze Y, Akimoto A, Fujita T. Restoration of immune responses in tumor-bearing mice by ONO-4007, an antitumor lipid A derivative. Immunopharmacology 1997;36:69-78.
9. Oida H, Aze Y, Matsumoto N. Induction of antitumor activity and intratumoral TNF production by ONO-4007, a synthetic lipid A analog. 20th Int Congress Chemother (Sydney), 1997;55.
10. Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth A ascites tumor in BALB/C mice. J Immunother 1988;7:371-83.
11. Nakajima M, Welch DR, Wynn DM, Tsuruo T, Nicolson GL. Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res 1993;53:5802-7.
12. Mizushima Y, Kashii T, Kobayashi M. Association between gene alteration and drug sensitivity in human lung carcinoma cell lines. Oncol Rep 1995;2:277-80.
13. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from kupffer cells. J Immunol 1996;156:2436-42.
14. Old LJ. Tumor necrosis factor (TNF). Science 1985;230:630-2.
15. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-70.
16. Haranaka K, Satomi N, Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 1984;34:263-7.
17. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccha-ride-binding acute phase reactant from rabbit serum. J Exp Med 1986;164:777-93.
18. Conti P, Dempsey RA, Reale M, et al. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumor necrosis factor and interleukin-6: effect of IL-1 receptor antagonist. Immunology 1991;73:450-6.
19. Weiss B, Sachs L. Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci USA 1978;75:1374-8.
20. Sato N, Goto T, Haranaka K, et al. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst 1981;76:1113-21.
21. Kawai T, Satomi N, Sato N, et al. Necrotizing activity of tumor necrosis factor: histopathological investigation using Meth A sarcoma and granulation tissue. Virchows Arch B 1987;53:353-8.